Almirall, S.a.
Clinical trials sponsored by Almirall, S.a., explained in plain language.
-
New hope for stubborn Coin-Shaped eczema: drug trial launches
Disease control Not yet recruitingThis study tests a new drug called lebrikizumab for adults with nummular eczema (coin-shaped patches) that doesn't get better with standard steroid creams. About 270 people will receive either the drug or a placebo to see if it clears the rash and reduces itching. The goal is to …
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for painful skin condition: experimental drug enters phase 2 trial
Symptom relief Not yet recruitingThis study tests whether the experimental drug LAD328 can reduce symptoms of moderate-to-severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. About 50 adults will receive either LAD328 or a placebo to compare effectiveness and safety. The main goal is …
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Symptom relief
Last updated May 17, 2026 08:00 UTC